Seeking Alpha

Canaccord Genuity analyst Randall Stanicky lines up three specialty pharmaceutical stocks with...

Canaccord Genuity analyst Randall Stanicky lines up three specialty pharmaceutical stocks with strong catalyst-driven upside potential before year-end: (1) Teva Pharmaceuticals (TEVA -0.3%) on generic Lipitor potential; (2) Inhibitex (INHX -0.1%) ahead of top-line results from INX-189; (3) Raptor (RPTP +0.3%) due to key six-month tolerability data set to be released in Dec.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector